These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 36257588)
1. Association between prehospital medication and fatal outcomes in a cohort of hospitalized patients due to coronavirus disease-2019 in a referral hospital in Peru. Caira-Chuquineyra B; Fernandez-Guzman D; Alvarez-Arias PM; Zarate-Curi ÁA; Herrera-Añazco P; Benites-Zapata VA Travel Med Infect Dis; 2022; 50():102472. PubMed ID: 36257588 [TBL] [Abstract][Full Text] [Related]
2. [Trends in drugs usage for COVID-19 during the first wave of the pandemic in a hospital in Lima, Peru]. Castro NE; García DR; Rivera MT; Rondán-Guerrero P; García-Rojas F; Taype-Rondan A Rev Peru Med Exp Salud Publica; 2021; 38(4):608-614. PubMed ID: 35385014 [TBL] [Abstract][Full Text] [Related]
3. Risk factors for mortality in hospitalized patients with COVID-19 from three hospitals in Peru: a retrospective cohort study. Díaz-Vélez C; Urrunaga-Pastor D; Romero-Cerdán A; Peña-Sánchez ER; Fernández Mogollon JL; Cossio Chafloque JD; Marreros Ascoy GC; Benites-Zapata VA F1000Res; 2021; 10():224. PubMed ID: 34211701 [TBL] [Abstract][Full Text] [Related]
4. Mortality and associated risk factors in patients hospitalized due to COVID-19 in a Peruvian reference hospital. Soto A; Quiñones-Laveriano DM; Azañero J; Chumpitaz R; Claros J; Salazar L; Rosales O; Nuñez L; Roca D; Alcantara A PLoS One; 2022; 17(3):e0264789. PubMed ID: 35235613 [TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
6. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial. Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of corticosteroids in non-intensive care unit patients with COVID-19 pneumonia from the New York Metropolitan region. Majmundar M; Kansara T; Lenik JM; Park H; Ghosh K; Doshi R; Shah P; Kumar A; Amin H; Chaudhari S; Habtes I PLoS One; 2020; 15(9):e0238827. PubMed ID: 32903258 [TBL] [Abstract][Full Text] [Related]
8. Corticosteroids for COVID-19 patients requiring oxygen support? Yes, but not for everyone: Effect of corticosteroids on mortality and intensive care unit admission in patients with COVID-19 according to patients' oxygen requirements. Tortajada C; Colomer E; Andreu-Ballester JC; Esparcia A; Oltra C; Flores J J Med Virol; 2021 Mar; 93(3):1817-1823. PubMed ID: 33107607 [TBL] [Abstract][Full Text] [Related]
9. Association between Prehospital Hypoxemia and Admission to Intensive Care Unit during the COVID-19 Pandemic: A Retrospective Cohort Study. Midez R; Fehlmann CA; Marti C; Larribau R; Rouyer F; Boroli F; Suppan L; Gartner BA Medicina (Kaunas); 2021 Dec; 57(12):. PubMed ID: 34946307 [No Abstract] [Full Text] [Related]
10. Oxygen saturation as a predictor of mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru. Mejía F; Medina C; Cornejo E; Morello E; Vásquez S; Alave J; Schwalb A; Málaga G PLoS One; 2020; 15(12):e0244171. PubMed ID: 33370364 [TBL] [Abstract][Full Text] [Related]
11. Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19. Liu Z; Li X; Fan G; Zhou F; Wang Y; Huang L; Yu J; Yang L; Shang L; Xie K; Xu J; Huang Z; Gu X; Li H; Zhang Y; Wang Y; Huang Z; Cao B Clin Microbiol Infect; 2021 Jan; 27(1):112-117. PubMed ID: 33007478 [TBL] [Abstract][Full Text] [Related]
13. Migration background and COVID-19 related intensive care unit admission and mortality in the Netherlands: A cohort study. Ocak G; Khairoun M; van Stigt Thans M; Meeder D; Moeniralam H; Dekker FW; Verhaar MC; Bos WJW; Kaasjager KAH PLoS One; 2023; 18(4):e0284036. PubMed ID: 37018329 [TBL] [Abstract][Full Text] [Related]
14. Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19. Gupta S; Wang W; Hayek SS; Chan L; Mathews KS; Melamed ML; Brenner SK; Leonberg-Yoo A; Schenck EJ; Radbel J; Reiser J; Bansal A; Srivastava A; Zhou Y; Finkel D; Green A; Mallappallil M; Faugno AJ; Zhang J; Velez JCQ; Shaefi S; Parikh CR; Charytan DM; Athavale AM; Friedman AN; Redfern RE; Short SAP; Correa S; Pokharel KK; Admon AJ; Donnelly JP; Gershengorn HB; Douin DJ; Semler MW; Hernán MA; Leaf DE; JAMA Intern Med; 2021 Jan; 181(1):41-51. PubMed ID: 33080002 [TBL] [Abstract][Full Text] [Related]
15. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study. Bartoletti M; Marconi L; Scudeller L; Pancaldi L; Tedeschi S; Giannella M; Rinaldi M; Bussini L; Valentini I; Ferravante AF; Potalivo A; Marchionni E; Fornaro G; Pascale R; Pasquini Z; Puoti M; Merli M; Barchiesi F; Volpato F; Rubin A; Saracino A; Tonetti T; Gaibani P; Ranieri VM; Viale P; Cristini F; Clin Microbiol Infect; 2021 Jan; 27(1):105-111. PubMed ID: 32971254 [TBL] [Abstract][Full Text] [Related]
17. Factors associated with mortality due to COVID-19 in patients from a public hospital in Tacna, Peru. Hueda-Zavaleta M; Copaja-Corzo C; Bardales-Silva F; Flores-Palacios R; Barreto-Rocchetti L; Benites-Zapata VA Rev Peru Med Exp Salud Publica; 2021; 38(2):214-223. PubMed ID: 34468567 [TBL] [Abstract][Full Text] [Related]
18. Survival analysis of COVID-19 patients in Ethiopia: A hospital-based study. Kaso AW; Agero G; Hurissa Z; Kaso T; Ewune HA; Hareru HE; Hailu A PLoS One; 2022; 17(5):e0268280. PubMed ID: 35533178 [TBL] [Abstract][Full Text] [Related]
19. Impact of previous exposure to systemic corticosteroids on unfavorable outcome in patients hospitalized for COVID-19. Lafaurie M; Martin-Blondel G; Delobel P; Kamar N; Charpentier S; Sommet A; Moulis G; BMC Pharmacol Toxicol; 2021 Mar; 22(1):14. PubMed ID: 33706794 [TBL] [Abstract][Full Text] [Related]
20. The first consecutive 5000 patients with Coronavirus Disease 2019 from Qatar; a nation-wide cohort study. Omrani AS; Almaslamani MA; Daghfal J; Alattar RA; Elgara M; Shaar SH; Ibrahim TBH; Zaqout A; Bakdach D; Akkari AM; Baiou A; Alhariri B; Elajez R; Husain AAM; Badawi MN; Abid FB; Abu Jarir SH; Abdalla S; Kaleeckal A; Choda K; Chinta VR; Sherbash MA; Al-Ismail K; Abukhattab M; Ait Hssain A; Coyle PV; Bertollini R; Frenneaux MP; Alkhal A; Al-Kuwari HM BMC Infect Dis; 2020 Oct; 20(1):777. PubMed ID: 33076848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]